40+ results for "AI"
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
COPENHAGEN, Denmark, August 25, 2026 – Bavarian Nordic A/S (OMX: BAVA) has today received information about the following transactions of the company’s shares/related securities by persons holding managerial responsibilities and/or persons/companies closely associated with such. 1. Details of the person discharging managerial responsibilities/person closely associated a) Name Paul Chaplin 2. Reason for the notification a) Position/status President and Chief Executive Officer of Bavarian Nordic A
Nika Pharmaceuticals, Inc. (OTCQB: NIKA) Funding Update
HENDERSON, Nev., Aug. 25, 2026 (GLOBE NEWSWIRE) -- Nika Pharmaceuticals, Inc. (OTCQB: NIKA ) is continuing its ongoing negotiation with investors from Thailand, Japan, Switzerland, Luxembourg, USA, Bulgaria, and the UAE for financing of up to 50 million US dollars. The Company has seen great interest, with most investors reaching out directly to NIKA. “We are striving to select the most suitable investor and partner for NIKA, for which reason the discussions surrounding the technical details of
Standard Process Launches GI Soothing Supplement for Dogs and Cats
New probiotic, postbiotic, and botanical formula provides comprehensive gastrointestinal support during periods of digestive upset or distress A Media Snippet accompanying this announcement is available by clicking on this link. PALMYRA, Wis., Aug. 25, 2026 (GLOBE NEWSWIRE) -- Standard Process® , a leader in whole food-based nutritional solutions, today announced GI Soothing , the newest addition to its Standard Process Veterinary line of human-quality supplements. Now available for preorder, GI
HCW Biologics’ TGF-β Trap and IL-15 Fusion is a Novel Moiety to Enhance Immunotherapeutic Activity against Diseased Cells
Human studies show that the TGF-β trap and IL-15 fusion used alone promotes expansion of progenitor CD8 + T cells and NK cells Company has incorporated the TGF-β/IL-15 moiety into the constructs of its second-generation fusion immunotherapeutics constructed with novel TRBC drug development platform MIRAMAR, Fla., Aug. 25, 2026 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), a U.S.-based clinical-stage biopharmaceutical company focused on developing novel
Nu-Tek BioSciences to Attend BPI East 2026 in Boston, Connecting Animal-Free Culture Media Nutrients with Pharma Customer Growth Strategies
Tour Nu-Tek's state-of-the-art, 100% animal-free manufacturing facilty. Soy Peptone Soy peptones are one of the many animal-free products in Nu-Tek's raw materials portfolio. Nu-Tek will meet with pharmaceutical leadership during BioProcess International East Sept. 22-25 in Boston to discuss 100% animal-origin-free peptones and protein hydrolysates, with a focus on product quality and supply security. MINNETONKA, Minn., Aug. 25, 2026 (GLOBE NEWSWIRE) -- Nu-Tek BioSciences, the market leader in 1
Sagimet Biosciences Advances AURORA U.S. Phase 3 Trial of Denifanstat in Acne Toward Patient Enrollment in Q4 2026
All clinical trial sites identified and CRO retained Patient screening expected to begin in October 2026, with first patient to be enrolled shortly after FOSTER CITY, Calif., Aug. 25, 2026 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways, today announced that its AURORA Phase 3 clinical trial of FASN inhibitor denifanstat in moderate to severe acne is on tr
Immatics Announces $150 Million Underwritten Offering
Houston, Texas and Tuebingen, Germany, August 25, 2026 – Immatics N.V. (NASDAQ: IMTX, “Immatics” or the “Company”), the global leader in precision targeting of PRAME with multiple clinical-stage programs spanning cell therapies and bispecifics, announced today that it has agreed to sell 12,945,916 ordinary shares at $8.69 per share and, in lieu of ordinary shares to certain investors, pre-funded warrants to purchase 4,315,304 ordinary shares at a purchase price of $8.689 per pre-funded warrant,
Beyond Air Enters Definitive Agreement to Sell Its NeuroNOS Stake to UNIVO Pharmaceutical Industries in Exchange for Equity and Milestone Payments
Beyond Air to receive shares representing 19.99% of Univo's issued and outstanding share capital upon closing Beyond Air eligible to receive up to $32.5 million in development and commercial milestone payments GARDEN CITY, N.Y., Aug. 25, 2026 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) today announced that they have entered into a definitive agreement under which UNIVO Pharmaceutical Industries Ltd (“UNIVO”) Univo Pharmaceutical Industries Ltd. ("UNIVO"), a public company whose shares ar
3CLogic Releases AI Agent Evaluator to Automate QA and Scoring of Voice AI Agents
New capability scores 100% of AI interactions with plain-language reasoning, enabling accountability and rich insights into Voice AI engagements and performance. ROCKVILLE, Md. , Aug. 25, 2026 -- 3CLogic today announced the release of AI Agent Evaluator , a powerful automated quality assurance (QA) and scoring engine built natively into its Voice AI Hub . The new feature scores 100% of Voice AI agent interactions based on configurable metrics including resolution, goal completion, and quality, while providing plain-language reasoning behind each rating without the need for manual transcript review.
KSAT Delivers Integrated Mission Services for Kongsberg's N3X Satellite Constellation for Norway's Maritime Domain Awareness
SALT LAKE CITY , Aug. 25, 2026 -- Following KONGSBERG s announcement of an expansion of its N3X maritime surveillance constellation, Kongsberg Satellite Services (KSAT) highlighted its role as the operational backbone of the program, delivering Integrated Mission Services (IMS) for one of Norway s most strategically important space capabilities. The N3X satellites, developed and deployed by KONGSBERG, already provide maritime surveillance data to Norwegian authorities. KSAT is responsible for satellite operations, mission planning, global ground station access, data processing, and data delivery.
ZeroBounce Can Now Detect AI-Managed Mailboxes
New data helps businesses identify mailboxes managed by autonomous AI agents, going beyond traditional email validation. SANTA BARBARA, Calif. , Aug. 25, 2026 -- ZeroBounce, the email validation and deliverability platform, today announced it can now detect AI-managed mailboxes , a new layer of email intelligence that identifies mailboxes managed primarily by autonomous AI agents rather than people. ZeroBounce is the first email validation platform to provide customers with this type of insight.
Metabolon Completes Landmark Global Health Pilot Advancing Women's and Infant Health
Innovative sample collection methods developed through Gates Foundation-funded grant enable high-quality metabolomics biomarker discovery in populations from low- and middle-income countries MORRISVILLE, N.C. , Aug. 25, 2026 -- Metabolon, Inc., the global leader in metabolomics solutions advancing life science research, diagnostics, therapeutics, and precision medicine, today announced the successful completion of multiple pilot projects funded by the Gates Foundation (the foundation). These projects aimed to identify metabolites strongly associated with clinical outcomes for diseases and conditions that disproportionately affect women and infants in low- and middle-income countries.
Spinnaker Support Names Rex Young Chief Information Officer as Company Scales Global Operations
Veteran Tech Leader Brings 25-Plus Years of IT, Cybersecurity, and AI Experience to Modernize Platforms and Strengthen Security DENVER, Colo. , Aug. 25, 2026 -- Spinnaker Support , the third-party software support leader entrusted by 1,300+ global clients, today announced the appointment of Rex Young as Chief Information Officer (CIO). Reporting to CEO Matt Stava, Young will lead Spinnaker s global technology strategy as the company expands to meet the accelerating global demand for Oracle, SAP, VMware, and PostgreSQL support.
Relativity Accelerates Enterprise AI Transformation with Google Cloud's Gemini Enterprise for Legal
News Summary: RelativityOne now integrates with Google Cloud s Gemini Enterprise for Legal through the Model Context Protocol (MCP). This integration enables shared users to accelerate enterprise workflows with increased speed and security. The MCP integration for Gemini Enterprise is another informed step toward strengthening the intuitive experience of the company s AI platform for legal data intelligence, expanding the legal work it supports by bringing it to legal professionals where and how they work.
Industry Leaders Call for Cooling Security to Become a National Priority as India Accelerates Towards Viksit Bharat 2047
Grundfos-led roundtable at ISHRAE CoOL Conclave 3.0 identifies district cooling as a strategic enabler of energy security, sustainable urbanization, and net-zero growth COIMBATORE, India, Aug. 25, 2026 -- As India experiences unprecedented urban growth, rising temperatures, and increasing demand for cooling, industry leaders, policymakers, urban planners, utilities, developers, academics, and sustainability experts convened at ISHRAE CoOL Conclave 3.0 in Coimbatore to discuss one critical question: how can India secure its cooling future while continuing its path towards sustainable growth and Viksit Bharat 2047?
Cambrex High Point Completes FDA, PMDA and TGA Pre-Approval Inspections, Advancing Commercial Manufacturing Capabilities
EAST RUTHERFORD, N.J. , Aug. 25, 2026 -- Cambrex, a leading global contract development and manufacturing organization (CDMO), today announced the successful completion of three Pre-Approval Inspections (PAIs) at its High Point, North Carolina facility by the U.S. Food and Drug Administration (FDA), Japan s Pharmaceuticals and Medical Devices Agency (PMDA), and Australia s Therapeutic Goods Administration (TGA). The completion of all three inspections enables High Point to manufacture approved active pharmaceutical ingredients (APIs) for the United States, Japan, and Australia, establishing the facility as the newest commercial manufacturing site within the Cambrex global network.
Chandigarh University CSE Student Builds Tech-Driven Startup to Help Businesses Across IT, Digital Marketing and Networking Grow Fast in the Digital Era
University s Engineering Student s Startup Habonix Media Receives Rs. 3 Lakh Startup Seed Grant from Punjab Government CHANDIGARH, India, Aug. 25, 2026 -- Combining technology and creativity to help businesses grow efficiently in a competitive digital market, a Chandigarh University (CU) alumnus, Sabhay Khera, has founded a startup Habonix Media Pvt Ltd a one-stop solution provider for IT services, helping MSMEs and growing businesses build, scale, and succeed in the digital space offering end-to-end services including web and mobile app development, UI/UX (User Interface and User Experience) design and performance marketing solutions tailored to each client s goals.
Rising Demand for Advanced Gynecological Care: Rainbow Children's Hospital Expands Surgical Capabilities for Women
HYDERABAD, India , Aug. 25, 2026 -- Rainbow Children s Hospital recently introduced robotic-assisted surgery in its gynaecology department at its Financial District facility in Hyderabad, marking a step forward in the centre s approach to complex gynecological procedures. The technology allows surgeons to operate with greater precision and control, translating into smaller incisions, reduced blood loss, and faster recovery for patients undergoing procedures for conditions such as fibroids, endometriosis, and other gynecological disorders requiring surgical intervention.
Fractal establishes India Business Unit to meet increasing demand from large Indian enterprises
Will leverage its products portfolio led by Cogentiq MUMBAI, India, Aug. 25, 2026 -- Fractal Analytics Ltd . (BSE: 544700) (NSE: FRACTAL), a global enterprise AI company serving Fortune 500 organizations, today announced the launch of its dedicated India Business Unit (India BU), to help India s large enterprises accelerate business transformation through its enterprise agentic AI platform, Cogentiq , and other products.
U.S. FDA Grants Orphan Drug Designation to Gamgertamig for the Treatment of Pemphigus
Mechelen, Belgium; 24 August 2026, 22.01 CET; regulated information – Lakefront Biotherapeutics NV (Euronext & NASDAQ: LKFT) today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to gamgertamig for the treatment of pemphigus. Gamgertamig was previously granted both Fast Track and Orphan Drug Designation by the U.S. FDA for the treatment of autoimmune hemolytic anemia (AIHA) and immune thrombocytopenia (ITP). Gamgertamig is being developed by Lakefro
ICP DAS-BMP Brings Advanced Medical TPU Portfolio to Medical Manufacturing Asia 2026
HSINCHU , Aug. 25, 2026 -- ICP DAS-BMP (Biomedical Polymers), a Taiwan-based manufacturer and supplier of medical-grade TPU (thermoplastic polyurethane), will exhibit at Medical Manufacturing Asia 2026, taking place September 9 11 at the Marina Bay Sands Expo & Convention Centre in Singapore (Booth 2U20) . Exhibiting together with its manufacturing partner, Towards Buddha Co., Ltd., the company will showcase its comprehensive medical TPU portfolio while also introducing integrated medical tubing extrusion and contract manufacturing (OEM/ODM) services for medical device manufacturers.
IPSEN - Buy-back programme - Art 5 of MAR - Week 34 - 2026
Aggregated presentation by day and by market Weekly report on share repurchases from 17 th to 21 st August 2026 Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial instrument Total daily volume (in number of shares) Daily weighted average purchase price of the shares Market (MIC Code) IPSEN 549300M6SGDPB4Z94P11 17/08/2026 FR0010259150 N/A N/A - IPSEN 549300M6SGDPB4Z94P11 18/08/2026 FR0010259150 N/A N/A - IPSEN 549300M6SGDPB4Z94P11 19/08/2026 FR0010259150
Applied Biologics CEO and Former Marine F/A-18 Pilot Edward Britt Selected as Honorary Commander at Luke Air Force Base
Former Marine Corps Captain selected to serve with leadership of the 56th Operational Medical Readiness Squadron SCOTTSDALE, Ariz., Aug. 24, 2026 (GLOBE NEWSWIRE) -- Applied Biologics today announced that Edward Britt, Chief Executive Officer of Applied Biologics and a former United States Marine Corps F/A-18 pilot, has been selected to serve as an Honorary Commander at Luke Air Force Base as part of the 56th Fighter Wing Honorary Commander Program. Britt has been selected as Honorary Commander
LEQEMBI IQLIK® (lecanemab-irmb) Autoinjector for Initiation of Therapy Now Available in the U.S. for Early Alzheimer’s Disease
LEQEMBI IQLIK is the first-of-its-kind anti-amyloid treatment worldwide offering at-home dosing for initiation and maintenance (approved in the U.S.) TOKYO and CAMBRIDGE, Mass., Aug. 24, 2026 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. and Biogen Inc. (Nasdaq: BIIB), announced today that once weekly lecanemab-irmb subcutaneous injection (brand name: LEQEMBI IQLIK ® ) is now available in the U.S. for initiation therapy for early Alzheimer’s disease (AD) in adults with mild cognitive impairment (MCI) or m
Kraig Biocraft Laboratories Boosts Spider Silk Output More Than 30% During the Most Technically Challenging Season of the Year
Company Achieves Record Growth Through Peak Rainy Season, with Management Confirming Even Greater Output Within Reach ANN ARBOR, Mich., Aug. 24, 2026 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company", "Kraig Labs", or "Kraig's"), a world leader in spider silk technology*, today announced that it has set another spider silk production record, increasing output by more than 30% over its previous record-setting levels. The milestone marks the Company's latest breakt
KSAT Opens Customer Demonstrations for HYPER Hybrid RF and Optical Relay Services
Multiple customer demonstrations will validate hybrid RF and optical relay services ahead of commercial deployment. SALT LAKE CITY , Aug. 24, 2026 -- Kongsberg Satellite Services (KSAT) today announced the first demonstration campaigns for Hyperion, the pathfinder mission for HYPER, KSAT s next-generation hybrid radio frequency (RF) and optical relay network. The campaigns will validate the operational services planned for the commercial HYPER network through demonstrations with satellite operators, technology providers and institutional partners, marking the first opportunity for customers to test low-latency relay services before commercial operations begin.
ShardLab Invests in StoreHub, Launches Joint Venture to Explore Next-Generation Payments and Rewards in Southeast Asia
KUALA LUMPUR, Malaysia , Aug. 24, 2026 -- ShardLab, a fintech venture studio backed by global investment firm Hashed, has made a strategic investment in StoreHub, one of Southeast Asia s leading commerce and payments platforms. The two companies will also form a joint venture to explore new consumer payment and rewards experiences for merchants and consumers across the region. StoreHub operates across Malaysia, the Philippines, Thailand and Japan, serving 20,000+ merchant locations. Its platform processes more than 200 million transactions annually, representing approximately US 3.5 billion in annual transaction value.
TME Pharma provides update on its activities
TME Pharma provides update on its activities TME Pharma enters the final evaluation phase of advanced discussions with two potential partners for a license agreement. Discussions and potential partnership are aimed at enabling the further development of the phase2-development of flagship product NOX-A12. NOX-A12 holds FDA and EU Orphan Drug and FDA Fast Track designations in glioblastoma, supported by recent peer-reviewed publication in Nature Communications . With estimated yearly peak sales po
IBM Study: Sports Fans Want Streamlined Digital Experiences as Platform Choices Expand
AI use among surveyed sports fans increased in 2026, with accuracy driving fan trust Nearly half of respondents would download a single, consolidated sports app -- but only about 3 in 10 would pay for one Managing multiple subscriptions has become a source of frustration for surveyed sports fans ARMONK, N.Y. , Aug. 24, 2026 -- New research commissioned by IBM (NYSE: IBM ) reveals the digital expectations of surveyed sports fans are rising as they navigate more platforms, subscriptions and technology.
IBM and the USTA Introduce New AI-Powered Fan Experiences for 2026 US Open
NEW YORK , Aug. 24, 2026 -- IBM (NYSE: IBM ) and the United States Tennis Association (USTA) today announced new and enhanced AI-powered fan features coming to USOpen.org and the US Open app for this year s tournament. Three new, enhanced AI-powered innovations are designed to help fans cut through the noise, stay closer to the action and experience the US Open in a more personalized way than ever. Since 1992, IBM and the USTA have brought some of the most advanced digital experiences in sports to more than 14 million global tennis fans annually.
HTX Research Examines U.S. AI Equities: Technology Remains Early, While Capital Expenditure and Valuations Have Entered the Late Cycle
APIA, Samoa , Aug. 23, 2026 -- HTX Research, the dedicated research arm of HTX, has released a new report titled The Industrialization of Intelligence and the Bubble Cycle: Token Economics, Capital Expenditure, and the Repricing of Risk-Reward Across U.S. AI Equities . Its central argument is that the AI industry and AI equities are not at the same point in their respective cycles technological diffusion remains in its early stages while capital expenditure, valuations, and investor sentiment have moved well ahead of it.
Chandigarh University Hosts Global Architectural Voices to Deliberate on Technology, Heritage and Future of Architecture
Leading Architects Deliberate Artificial Intelligence, Emerging Technologies & the Future of Architecture CHANDIGARH, India , Aug. 22, 2026 -- Aimed at transforming industry academia engagement from dialogue into tangible collaboration, the 4th International Conference on Trends in Architecture and Construction (ICTAC 2026) was inaugurated today at Chandigarh University, bringing leading architects, academicians, researchers, industry professionals and scholars onto a single platform to deliberate on the future of architecture and construction.
Jury Finds in Cytek’s Favor on Three of Four Asserted Claims; Company to Challenge Remaining Finding
FREMONT, Calif., Aug. 21, 2026 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences,” “Cytek,” or the “Company”) (Nasdaq: CTKB), a leading cell analysis solutions company, today announced that a jury in the United States District Court for the District of Delaware returned a verdict in the patent infringement action brought by Beckman Coulter, Inc. The jury found in Cytek’s favor on three of the four asserted patent claims, finding noninfringement and invalidity as to each of those th
NurExone Announces Annual General and Special Meeting to Consider Share Consolidation in Support of U.S. Capital Markets Strategy
Proposed share consolidation of up to 30:1 intended to support potential U.S. exchange listing and broaden investor appeal TORONTO and HAIFA, Israel, Aug. 21, 2026 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (“ NurExone ” or the “ Company ”) (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) is pleased to announce that it will hold its annual general and special meeting of shareholders on September 15, 2026 (the “ Meeting ”) to seek shareholder approval for a special resolution authorizing the board of direct
Werewolf Therapeutics and Ambros Therapeutics Announce Merger Agreement and Concurrent Oversubscribed $150 Million Private Placement
Proposed merger to create a Nasdaq-listed, late-stage biotechnology company advancing neridronate, a potential first FDA-approved treatment for CRPS-1, a debilitating orphan disease with 65,000 newly diagnosed U.S. patients annually and no currently FDA-approved therapy Pivotal CRPS-RISE Phase 3 trial evaluating neridronate remains ongoing, with FDA Breakthrough Therapy, Fast Track and Orphan Drug designations received and alignment with FDA that a single successful pivotal trial could potential
Zhang Ziyi: the new face of Clarins Precious
PARIS , Aug. 21, 2026 -- Clarins is proud to announce Zhang Ziyi as Clarins Precious Global spokesperson. The Chinese actress, director and producer is a globally recognized icon of cinema whose singular talent has earned world-wide acclaim. As part of her new role, she will champion authentic beauty, rare innovation and the exceptional craftmanship of Clarins Precious, our premium skin care line built on decades of scientific expertise, meticulous formulation and a relentless pursuit of excellence.
European Commission approves Johnson & Johnson’s TECVAYLI®▼ (teclistamab) plus daratumumab for relapsed/refractory multiple myeloma, offering a potential new standard of care
Approval is based on unprecedented Phase 3 data showing statistically significant improvements in progression-free and overall survival versus standard of care regimens 1 This immunotherapy doublet regimen demonstrated durable disease control as early as second line, with more than 90% of patients who were progression-free at six months remaining progression-free at three years 1 BEERSE, BELGIUM, Aug. 21, 2026 (GLOBE NEWSWIRE) -- Johnson & Johnson today announced that the European Commission (EC
Bavarian Nordic to Launch New Share Buy-back Program of up to DKK 750 Million
Repurchased shares will be subject to cancellation, pending shareholder resolution COPENHAGEN, Denmark, August 21, 2026 – Bavarian Nordic A/S (OMX: BAVA) today announced its plans to launch a new share buy-back program of up to DKK 750 million, starting in the third quarter of 2026. The program reflects the Company's continued commitment to create shareholder value through a capital allocation policy that balances short-term distribution of capital to the shareholders against the longer-term sha
Colgate-Palmolive elevates Prabha Narasimhan to EVP - Marketing, Asia-Pacific and announces Manish Anandani as new MD & CEO for India
MUMBAI, India , Aug. 21, 2026 -- Colgate-Palmolive India Limited today announced a key leadership transition. Prabha Narasimhan, Managing Director and Chief Executive O cer, has been elevated to the role of Executive Vice President Marketing, Asia-Pacific Division, Colgate-Palmolive, effective close of business hours on 27 September, 2026. To lead the company into its next growth phase, the Board of Directors has approved the appointment of Manish Anandani as Managing Director and Chief Executive O cer, effective 28 September, 2026.
NUMR Inc. helps deliver Axis Bank's data-driven excellence in customer experience
The initiative was recognized at the BFSI Summit for effectively translating customer insights into measurable business outcomes MUMBAI, India , Aug. 21, 2026 -- NUMR Inc., a leading AI-driven customer experience management platform, supports Axis Bank in delivering actionable journey insights that enable smarter decision-making across high-value customer touchpoints. Axis Bank was recently recognised for CX Data & Analytics Excellence at the BFSI Summit 2026. The award acknowledged the Bank s approach in embedding customer insights into everyday decision-making across key businesses, including retail banking, cards, and wealth management.